148 related articles for article (PubMed ID: 21567493)
1. Targeting norovirus infection-multivalent entry inhibitor design based on NMR experiments.
Rademacher C; Guiard J; Kitov PI; Fiege B; Dalton KP; Parra F; Bundle DR; Peters T
Chemistry; 2011 Jun; 17(27):7442-53. PubMed ID: 21567493
[TBL] [Abstract][Full Text] [Related]
2. "Double-click" protocol for synthesis of heterobifunctional multivalent ligands: toward a focused library of specific norovirus inhibitors.
Guiard J; Fiege B; Kitov PI; Peters T; Bundle DR
Chemistry; 2011 Jun; 17(27):7438-41. PubMed ID: 21469230
[No Abstract] [Full Text] [Related]
3. Library screen for inhibitors targeting norovirus binding to histo-blood group antigen receptors.
Feng X; Jiang X
Antimicrob Agents Chemother; 2007 Jan; 51(1):324-31. PubMed ID: 17060523
[TBL] [Abstract][Full Text] [Related]
4. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
LoBue AD; Lindesmith L; Yount B; Harrington PR; Thompson JM; Johnston RE; Moe CL; Baric RS
Vaccine; 2006 Jun; 24(24):5220-34. PubMed ID: 16650512
[TBL] [Abstract][Full Text] [Related]
5. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.
Foloppe N; Chen IJ; Davis B; Hold A; Morley D; Howes R
Bioorg Med Chem; 2004 Mar; 12(5):935-47. PubMed ID: 14980606
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
Koromyslova AD; Hansman GS
PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
[TBL] [Abstract][Full Text] [Related]
7. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening.
Wang YS; Liu D; Wyss DF
Magn Reson Chem; 2004 Jun; 42(6):485-9. PubMed ID: 15137040
[TBL] [Abstract][Full Text] [Related]
8. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.
Ali ES; Rajapaksha H; Carr JM; Petrovsky N
Antiviral Res; 2016 Sep; 133():14-22. PubMed ID: 27421712
[TBL] [Abstract][Full Text] [Related]
9. Rational optimization of the binding affinity of CD4 targeting peptidomimetics with potential anti HIV activity.
Neffe AT; Bilang M; Grüneberg I; Meyer B
J Med Chem; 2007 Jul; 50(15):3482-8. PubMed ID: 17602545
[TBL] [Abstract][Full Text] [Related]
10. Saturation transfer difference nuclear magnetic resonance titrations reveal complex multistep-binding of l-fucose to norovirus particles.
Mallagaray A; Rademacher C; Parra F; Hansman G; Peters T
Glycobiology; 2017 Jan; 27(1):80-86. PubMed ID: 27496762
[TBL] [Abstract][Full Text] [Related]
11. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
[TBL] [Abstract][Full Text] [Related]
12. 2-Substituted-4,5-dihydroxypyrimidine-6-carboxamide antiviral targeted libraries.
Boyd VA; Mason J; Hanumesh P; Price J; Russell CJ; Webb TR
J Comb Chem; 2009; 11(6):1100-4. PubMed ID: 19754047
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking.
Neffe AT; Bilang M; Meyer B
Org Biomol Chem; 2006 Sep; 4(17):3259-67. PubMed ID: 17036114
[TBL] [Abstract][Full Text] [Related]
14. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
15. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
[TBL] [Abstract][Full Text] [Related]
16. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
[TBL] [Abstract][Full Text] [Related]
17. Virus-ligand interactions: identification and characterization of ligand binding by NMR spectroscopy.
Benie AJ; Moser R; Bäuml E; Blaas D; Peters T
J Am Chem Soc; 2003 Jan; 125(1):14-5. PubMed ID: 12515488
[TBL] [Abstract][Full Text] [Related]
18. Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Bodoor K; Boyapati V; Gopu V; Boisdore M; Allam K; Miller J; Treleaven WD; Weldeghiorghis T; Aboul-ela F
J Med Chem; 2009 Jun; 52(12):3753-61. PubMed ID: 19445516
[TBL] [Abstract][Full Text] [Related]
19. NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein.
Hajduk PJ; Dinges J; Miknis GF; Merlock M; Middleton T; Kempf DJ; Egan DA; Walter KA; Robins TS; Shuker SB; Holzman TF; Fesik SW
J Med Chem; 1997 Sep; 40(20):3144-50. PubMed ID: 9379433
[TBL] [Abstract][Full Text] [Related]
20. Binding of recombinant norovirus like particle to histo-blood group antigen on cells in the lumen of pig duodenum.
Tian P; Jiang X; Zhong W; Jensen HM; Brandl M; Bates AH; Engelbrektson AL; Mandrell R
Res Vet Sci; 2007 Dec; 83(3):410-8. PubMed ID: 17379264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
